Clinical utility of cerebrospinal fluid biomarkers measured by LUMIPULSE® system
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51681
Abstract: Cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) are well‐established in research settings, but their use in routine clinical practice remains a largely unexploited potential. Here, we examined the relationship between CSF biomarkers, measured by… read more here.
Keywords: biomarkers measured; cerebrospinal fluid; clinical utility; utility cerebrospinal ... See more keywords